United American Healthcare Corporation (UAHC)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -8000.00 USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -16 Thousand USD | 0.0% |
| 2019 | -16 Thousand USD | 0.0% |
| 2013 | 3.62 Million USD | 24.62% |
| 2012 | 2.9 Million USD | -25.68% |
| 2011 | 3.91 Million USD | 293.66% |
| 2010 | 994 Thousand USD | -84.66% |
| 2009 | 6.47 Million USD | -65.28% |
| 2008 | 18.65 Million USD | 8.64% |
| 2007 | 17.17 Million USD | -5.19% |
| 2006 | 18.11 Million USD | -17.87% |
| 2005 | 22.05 Million USD | 2.34% |
| 2004 | 21.55 Million USD | -10.56% |
| 2003 | 24.09 Million USD | -3.71% |
| 2002 | 25.02 Million USD | -42.68% |
| 2001 | 43.66 Million USD | 25.86% |
| 2000 | 34.68 Million USD | 3.24% |
| 1999 | 33.6 Million USD | -4.82% |
| 1998 | 35.3 Million USD | -33.02% |
| 1997 | 52.7 Million USD | -27.91% |
| 1996 | 73.1 Million USD | 75.72% |
| 1995 | 41.6 Million USD | 89.09% |
| 1994 | 22 Million USD | -1.79% |
| 1993 | 22.4 Million USD | -9.31% |
| 1992 | 24.7 Million USD | 2.49% |
| 1991 | 24.1 Million USD | 161.96% |
| 1990 | 9.2 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2000.00 USD | 0.0% |
| 2023 Q2 | -2000.00 USD | 0.0% |
| 2023 Q1 | -2000.00 USD | 0.0% |
| 2023 Q3 | - USD | 100.0% |
| 2023 FY | -8000.00 USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 Q1 | -6000.00 USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -9000.00 USD | -50.0% |
| 2020 FY | -16 Thousand USD | 0.0% |
| 2019 FY | -16 Thousand USD | 0.0% |
| 2018 Q2 | 1.54 Million USD | 30.74% |
| 2018 Q1 | 1.18 Million USD | 0.0% |
| 2018 Q3 | 1.95 Million USD | 26.81% |
| 2018 Q4 | 1.69 Million USD | -13.59% |
| 2017 Q3 | 901.00 USD | 0.0% |
| 2016 Q3 | 836.00 USD | 0.0% |
| 2014 Q2 | 866 Thousand USD | 181.17% |
| 2014 Q1 | 308 Thousand USD | 0.0% |
| 2014 Q3 | 644 Thousand USD | -25.64% |
| 2013 Q3 | 415 Thousand USD | -57.61% |
| 2013 Q2 | 979 Thousand USD | -8.42% |
| 2013 Q1 | 1.06 Million USD | 37.94% |
| 2013 FY | 3.62 Million USD | 24.62% |
| 2012 Q2 | 1.1 Million USD | 91.32% |
| 2012 Q4 | 775 Thousand USD | -3.13% |
| 2012 FY | 2.9 Million USD | -25.68% |
| 2012 Q1 | 576 Thousand USD | 15.2% |
| 2012 Q3 | 800 Thousand USD | -27.4% |
| 2011 Q1 | 904 Thousand USD | -19.29% |
| 2011 FY | 3.91 Million USD | 293.66% |
| 2011 Q4 | 500 Thousand USD | -31.32% |
| 2011 Q3 | 728 Thousand USD | -15.64% |
| 2011 Q2 | 863 Thousand USD | -4.54% |
| 2010 FY | 994 Thousand USD | -84.66% |
| 2010 Q3 | 1 Million USD | 270.11% |
| 2010 Q2 | 271 Thousand USD | -6.87% |
| 2010 Q1 | 291 Thousand USD | -27.43% |
| 2010 Q4 | 1.12 Million USD | 11.67% |
| 2009 Q2 | 510 Thousand USD | 1407.69% |
| 2009 Q4 | 401 Thousand USD | 1193.55% |
| 2009 Q3 | 31 Thousand USD | -93.92% |
| 2009 Q1 | -39 Thousand USD | -101.55% |
| 2009 FY | 6.47 Million USD | -65.28% |
| 2008 Q3 | 3.97 Million USD | -3.17% |
| 2008 Q2 | 4.1 Million USD | -28.53% |
| 2008 Q1 | 5.73 Million USD | -18.6% |
| 2008 FY | 18.65 Million USD | 8.64% |
| 2008 Q4 | 2.51 Million USD | -36.55% |
| 2007 Q3 | 6.18 Million USD | 35.94% |
| 2007 Q2 | 4.55 Million USD | 7.74% |
| 2007 Q4 | 7.04 Million USD | 13.9% |
| 2007 FY | 17.17 Million USD | -5.19% |
| 2007 Q1 | 4.22 Million USD | 0.05% |
| 2006 Q3 | 4.17 Million USD | -13.69% |
| 2006 FY | 18.11 Million USD | -17.87% |
| 2006 Q1 | 4.27 Million USD | -4.72% |
| 2006 Q2 | 4.83 Million USD | 13.02% |
| 2006 Q4 | 4.22 Million USD | 1.17% |
| 2005 FY | 22.05 Million USD | 2.34% |
| 2005 Q1 | 5.57 Million USD | 3.28% |
| 2005 Q2 | 5.69 Million USD | 2.26% |
| 2005 Q4 | 4.49 Million USD | -0.36% |
| 2005 Q3 | 4.5 Million USD | -20.92% |
| 2004 FY | 21.55 Million USD | -10.56% |
| 2004 Q4 | 5.39 Million USD | 0.13% |
| 2004 Q3 | 5.38 Million USD | 1.11% |
| 2004 Q2 | 5.33 Million USD | -3.91% |
| 2004 Q1 | 5.54 Million USD | 8.94% |
| 2003 Q4 | 5.09 Million USD | -4.98% |
| 2003 Q2 | 4.66 Million USD | -1.14% |
| 2003 Q1 | 4.71 Million USD | -41.35% |
| 2003 FY | 24.09 Million USD | -3.71% |
| 2003 Q3 | 5.35 Million USD | 14.93% |
| 2002 Q1 | 8.15 Million USD | -20.54% |
| 2002 Q2 | -4.02 Million USD | -149.33% |
| 2002 Q3 | 9.68 Million USD | 340.78% |
| 2002 Q4 | 8.04 Million USD | -16.96% |
| 2002 FY | 25.02 Million USD | -42.68% |
| 2001 Q1 | 12.98 Million USD | 11.98% |
| 2001 Q3 | 11.22 Million USD | 27.59% |
| 2001 Q4 | 10.26 Million USD | -8.61% |
| 2001 FY | 43.66 Million USD | 25.86% |
| 2001 Q2 | 8.79 Million USD | -32.26% |
| 2000 Q1 | 13.02 Million USD | 60.8% |
| 2000 Q4 | 11.59 Million USD | 17.77% |
| 2000 FY | 34.68 Million USD | 3.24% |
| 2000 Q2 | 5.62 Million USD | -56.81% |
| 2000 Q3 | 9.84 Million USD | 75.09% |
| 1999 Q3 | 7.9 Million USD | -25.47% |
| 1999 FY | 33.6 Million USD | -4.82% |
| 1999 Q4 | 8.1 Million USD | 2.53% |
| 1999 Q1 | 7.8 Million USD | 4.0% |
| 1999 Q2 | 10.6 Million USD | 35.9% |
| 1998 Q2 | 10.1 Million USD | 12.22% |
| 1998 Q3 | 7.8 Million USD | -22.77% |
| 1998 Q4 | 7.5 Million USD | -3.85% |
| 1998 FY | 35.3 Million USD | -33.02% |
| 1998 Q1 | 9 Million USD | 32.35% |
| 1997 Q2 | -4.1 Million USD | -120.2% |
| 1997 FY | 52.7 Million USD | -27.91% |
| 1997 Q3 | 9.3 Million USD | 326.83% |
| 1997 Q1 | 20.3 Million USD | 16.0% |
| 1997 Q4 | 6.8 Million USD | -26.88% |
| 1996 FY | 73.1 Million USD | 75.72% |
| 1996 Q4 | 17.5 Million USD | -7.89% |
| 1996 Q3 | 19 Million USD | -18.45% |
| 1996 Q2 | 23.3 Million USD | 40.36% |
| 1996 Q1 | 16.6 Million USD | 110.13% |
| 1995 Q2 | 9.4 Million USD | -16.07% |
| 1995 FY | 41.6 Million USD | 89.09% |
| 1995 Q4 | 7.9 Million USD | -19.39% |
| 1995 Q3 | 9.8 Million USD | 4.26% |
| 1995 Q1 | 11.2 Million USD | 6.67% |
| 1994 Q2 | 7.6 Million USD | 49.02% |
| 1994 Q1 | 5.1 Million USD | 13.33% |
| 1994 FY | 22 Million USD | -1.79% |
| 1994 Q4 | 10.5 Million USD | 3.96% |
| 1994 Q3 | 10.1 Million USD | 32.89% |
| 1993 Q1 | 6.9 Million USD | 4.55% |
| 1993 FY | 22.4 Million USD | -9.31% |
| 1993 Q4 | 4.5 Million USD | -11.76% |
| 1993 Q3 | 5.1 Million USD | -41.38% |
| 1993 Q2 | 8.7 Million USD | 26.09% |
| 1992 Q1 | 6.5 Million USD | 8.33% |
| 1992 Q2 | 6.5 Million USD | 0.0% |
| 1992 Q3 | 6.8 Million USD | 4.62% |
| 1992 FY | 24.7 Million USD | 2.49% |
| 1992 Q4 | 6.6 Million USD | -2.94% |
| 1991 Q3 | 5.7 Million USD | -3.39% |
| 1991 Q1 | 6.1 Million USD | -31.46% |
| 1991 Q2 | 5.9 Million USD | -3.28% |
| 1991 FY | 24.1 Million USD | 161.96% |
| 1991 Q4 | 6 Million USD | 5.26% |
| 1990 FY | 9.2 Million USD | 0.0% |
| 1990 Q2 | 6.3 Million USD | 1.61% |
| 1990 Q4 | 8.9 Million USD | 1.14% |
| 1990 Q1 | 6.2 Million USD | 0.0% |
| 1990 Q3 | 8.8 Million USD | 39.68% |
| 1989 Q3 | 6.2 Million USD | 0.0% |
| 1989 Q4 | 6.2 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 101.715% |
| IR-Med Inc. | -17 Thousand USD | 52.941% |
| Polarean Imaging plc | 335.48 Thousand USD | 102.385% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 100.455% |
| Avitar, Inc. | 836.7 Thousand USD | 100.956% |
| AVITA Medical, Inc. | 41.68 Million USD | 100.019% |
| Manhattan Scientifics, Inc. | -1000.00 USD | -700.0% |
| Össur hf. | 485.57 Million USD | 100.002% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 95.904% |
| QHSLab, Inc. | 793.6 Thousand USD | 101.008% |
| Wellstar International, Inc. | - USD | Infinity% |
| Össur hf. | 485.57 Million USD | 100.002% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 100.048% |
| Escalon Medical Corp. | 5.14 Million USD | 100.155% |
| Aurora Spine Corporation | 8.21 Million USD | 100.097% |
| BrainsWay Ltd. | 23.09 Million USD | 100.035% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | 107.612% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 100.023% |
| Vivos Inc. | -6036.00 USD | -32.538% |
| MicroPort Scientific Corporation | 532.09 Million USD | 100.002% |
| Kelyniam Global, Inc. | 2.03 Million USD | 100.393% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 98.943% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 114.136% |
| Nanomix Corporation | -69.45 Thousand USD | 88.482% |
| Theraclion SA | -1.08 Million USD | 99.26% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 101.362% |
| Positron Corporation | -353.46 Thousand USD | 97.737% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 100.765% |
| Lombard Medical, Inc. | 955 Thousand USD | 100.838% |
| ALR Technologies Inc. | 4945.00 USD | 261.78% |
| Stratec SE | 71.58 Million USD | 100.011% |
| Vycor Medical, Inc. | 1.31 Million USD | 100.608% |
| Heart Tronics, Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 37.984% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 103.876% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 100.056% |
| VMS Rehab Systems, Inc. | -10.44 USD | -76528.352% |
| Guided Therapeutics, Inc. | 36 Thousand USD | 122.222% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 102.979% |
| Odyssey Group International, Inc. | - USD | Infinity% |
| ECGI Holdings, Inc. | - USD | Infinity% |
| Capital Group Holdings, Inc. | - USD | Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 100.731% |
| Urologix, Inc. | 6.09 Million USD | 100.131% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 97.474% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 101.121% |
| Qualis Innovations, Inc. | - USD | Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 100.0% |
| NIOX Group Plc | 28.13 Million USD | 100.028% |
| Fuse Medical, Inc. | 10.73 Million USD | 100.075% |
| Broncus Holding Corporation | 7.22 Million USD | 100.111% |
| Brain Scientific Inc. | 54.32 Thousand USD | 114.726% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 101.001% |
| Health Logic Interactive Inc. | - USD | Infinity% |